Blueprint Medicines shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $8.1M | 88k | 92.50 |
| 2024-06-30 | $9.9M | 92k | 107.78 |
| 2024-03-31 | $8.2M | 86k | 94.86 |
| 2023-12-31 | $7.8M | 84k | 92.24 |
| 2023-09-30 | $4.3M | 85k | 50.22 |
| 2023-06-30 | $5.3M | 84k | 63.20 |
| 2023-03-31 | $3.7M | 81k | 44.99 |
| 2022-12-31 | $3.5M | 81k | 43.81 |
| 2022-09-30 | $5.2M | 79k | 65.89 |
| 2022-06-30 | $3.6M | 72k | 50.51 |
| 2022-03-31 | $4.1M | 63k | 63.88 |
| 2021-12-31 | $6.7M | 63k | 107.10 |
| 2021-09-30 | $6.6M | 64k | 102.81 |
| 2021-06-30 | $5.5M | 63k | 87.96 |
| 2021-03-31 | $6.0M | 62k | 97.23 |
| 2020-12-31 | $7.8M | 70k | 112.15 |
| 2020-09-30 | $6.3M | 68k | 92.70 |
| 2020-06-30 | $6.6M | 85k | 78.00 |
| 2020-03-31 | $4.4M | 76k | 58.48 |
| 2019-12-31 | $5.7M | 71k | 80.10 |
| 2019-09-30 | $5.0M | 68k | 73.48 |
| 2019-06-30 | $6.4M | 68k | 94.34 |
| 2019-03-31 | $4.4M | 55k | 80.04 |
| 2018-12-31 | $3.0M | 55k | 53.91 |
| 2018-09-30 | $3.0M | 38k | 78.05 |
| 2018-06-30 | $2.6M | 41k | 63.47 |
| 2018-03-31 | $3.8M | 41k | 91.69 |
| 2017-12-31 | $3.1M | 41k | 75.41 |
| 2017-09-30 | $3.1M | 45k | 69.66 |
| 2017-06-30 | $2.2M | 44k | 50.66 |
| 2017-03-31 | $1.1M | 27k | 39.99 |
| 2016-12-31 | $597k | 21k | 28.06 |
| 2016-09-30 | $591k | 20k | 29.68 |
| 2016-06-30 | $329k | 16k | 20.26 |
| 2015-12-31 | $239k | 9.1k | 26.39 |
| 2015-06-30 | $204k | 7.7k | 26.46 |